LUCCHESI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 549
EU - Europa 417
AS - Asia 229
AF - Africa 51
OC - Oceania 1
SA - Sud America 1
Totale 1.248
Nazione #
US - Stati Uniti d'America 546
SE - Svezia 113
SG - Singapore 92
GB - Regno Unito 78
IT - Italia 73
CN - Cina 63
DE - Germania 62
IN - India 31
IE - Irlanda 29
TG - Togo 25
VN - Vietnam 21
NG - Nigeria 17
FR - Francia 13
RU - Federazione Russa 9
CH - Svizzera 8
ID - Indonesia 8
BG - Bulgaria 7
FI - Finlandia 7
BE - Belgio 6
JO - Giordania 6
CI - Costa d'Avorio 5
EE - Estonia 4
ZA - Sudafrica 4
CA - Canada 3
HK - Hong Kong 3
LB - Libano 3
DK - Danimarca 2
AU - Australia 1
CL - Cile 1
ES - Italia 1
MC - Monaco 1
MD - Moldavia 1
MY - Malesia 1
PL - Polonia 1
RO - Romania 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 1.248
Città #
Singapore 84
Chandler 79
Southend 73
Santa Clara 47
Fairfield 42
Princeton 32
Dublin 29
Ashburn 27
Lomé 25
Woodbridge 25
Houston 24
Boardman 22
Seattle 20
Turin 19
Abeokuta 17
Cambridge 15
Ann Arbor 12
Wilmington 12
Bologna 11
Berlin 10
Des Moines 9
San Diego 9
Bern 8
Jakarta 8
Beijing 7
Nanjing 7
New York 7
Sofia 7
Amman 6
Brussels 6
Westminster 6
Abidjan 5
Guangzhou 5
Rome 5
Bremen 4
Falls Church 4
Helsinki 4
Phoenix 4
Romainville 4
Forlì 3
Frankfurt am Main 3
Hong Kong 3
Hyderabad 3
Los Angeles 3
Padova 3
Saint Petersburg 3
Toronto 3
Wuhan 3
Xi'an 3
Bühl 2
Catanzaro 2
Chieti 2
Copenhagen 2
Foshan 2
Fremont 2
Hebei 2
Jinan 2
Lappeenranta 2
London 2
Medford 2
Munich 2
Pune 2
Shanghai 2
Shenyang 2
Verona 2
Ashland 1
Bari 1
Beirut 1
Boydton 1
Buffalo 1
Cento 1
Changchun 1
Changsha 1
Changzhou 1
Chengdu 1
Chisinau 1
Dongyang 1
Falkenstein 1
Fayetteville 1
Florence 1
Flushing 1
Gaomi 1
Hangzhou 1
Hanoi 1
Harbin 1
Kaifeng 1
Kuala Lumpur 1
Kunming 1
Laojunmiao 1
Leeds 1
Linyi 1
Ljubljana 1
Madrid 1
Melbourne 1
Miami 1
Monaco 1
Mountain View 1
Nanchang 1
Nanyang 1
North Bergen 1
Totale 837
Nome #
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients 135
Patologic IL 17 Producing Helper T Cells In Acute Myeloid Leukemia Patients 118
Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy. 110
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report 104
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients 91
null 77
Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin? 71
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years. 66
Tapering and discontinuation of thrombopoietin receptor agonists in immune thrombocytopenia: Real-world recommendations 56
Management of kidney transplantation in a factor VII-deficient patient: Case report 56
Managing chronic myeloid leukemia for treatment-free remission: A proposal from the GIMEMA CML WP 52
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report 52
Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study 50
Platelets beyond their count, as a key element of the innate immune system in the fight against malaria 46
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment 42
IL-17/IL-10 double-producing T cells: New link between infections, immunosuppression and acute myeloid leukemia 40
Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools 38
Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: Results from the ITACa trial 37
ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment 34
Immune thrombocytopenia in antiphospholipid syndrome: Is it primary or secondary? 19
Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis 11
Totale 1.305
Categoria #
all - tutte 4.910
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.910


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202099 0 0 0 0 0 12 19 22 24 9 11 2
2020/202191 17 4 3 0 1 4 5 6 5 6 10 30
2021/2022282 7 2 27 33 21 24 1 22 17 17 68 43
2022/2023414 28 74 21 41 39 34 15 21 72 10 44 15
2023/202482 4 19 4 3 7 17 1 11 6 5 4 1
2024/2025259 28 67 38 44 65 17 0 0 0 0 0 0
Totale 1.305